Simvastatin: between clinics and health economics
Statins reduce the incidence of cardiovascular events, one of the most important public health problems and among the main leading causes of death. Their use has been increasing in the last decade and today they represent the first drug class in terms of public expenditure. In view of the introducti...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
SEEd Medical Publishers
2007-03-01
|
Series: | Farmeconomia: Health Economics and Therapeutic Pathways |
Subjects: | |
Online Access: | https://journals.seedmedicalpublishers.com/index.php/FE/article/view/253 |